SYNAGEVA BIOPHARMA CORP - COM (GEVA)

CUSIP: 87159A103

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / COM
Total 13F shares
50,085
Share change
-165,838
Total reported value
$3,175,000
Price per share
$63.40
Number of holders
2
Value change
-$10,512,189
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 87159A103?
CUSIP 87159A103 identifies GEVA - SYNAGEVA BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNAGEVA BIOPHARMA CORP - COM (GEVA) as of Q3 2013

As of 30 Sep 2013, SYNAGEVA BIOPHARMA CORP - COM (GEVA) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,085 shares. The largest 2 holders included WELLS FARGO & COMPANY/MN and BANK OF MONTREAL /CAN/. This page lists 2 institutional shareholders reporting positions in this security for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.